SCHEMBL1260959

SCHEMBL1260959

CCC(C)C(=O)C(CC)(C(=O)O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2322015 0.77
Hydrochloric Acid SCHEMBL3267215 0.77 FFAR3 (0.39)
Hydrochloric Acid SCHEMBL627728 0.77 FFAR3 (0.39)
Hydrochloric Acid SCHEMBL28434900 0.77 FFAR3 (0.39)
SCHEMBL115741 0.74 FFAR3 (0.41)
SCHEMBL16465221 0.73
SCHEMBL28419811 0.72 FFAR3 (0.39)
Water SCHEMBL5129171 0.72 FFAR3 (0.39)
SCHEMBL12060203 0.71 TSHR (0.31)
Hydrogen Sulfide SCHEMBL28099749 0.71 TSHR (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8445509-B2 Fused heterocyclic derivatives and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-05-21 US disclosed
US-20110046169-A1 FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-02-24 US disclosed
WO-2009136663-A1 FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-12 WO disclosed